Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2010 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 9,644 |
| Marketable Securities | 1,131 |
| Receivables | 3,373,104 |
| Inventories | 836,270 |
| Income taxes - deferred | 1,636,811 |
| Other current assets | 1,872,490 |
| TOTAL | $8,218,493 |
| Non-Current Assets | |
| PPE Net | 2,357,563 |
| Investments And Advances | 137,360 |
| Intangibles | 9,888,360 |
| Other Non-Current Assets | 532,929 |
| TOTAL | $12,916,212 |
| Total Assets | $21,134,705 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 356,784 |
| Accrued Expenses | 1,556,106 |
| TOTAL | $3,761,248 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 1,670,458 |
| TOTAL | $1,670,458 |
| Total Liabilities | $5,431,706 |
| Shareholders' Equity | |
| Other shareholders' equity | 15,702,999 |
| TOTAL | $15,702,999 |
| Total Liabilities And Equity | $21,134,705 |